ClinicalTrials.gg
Sign In

Breast Cancer Lymphedema clinical trials

The registry lists 124 studies for Breast Cancer Lymphedema across more than 10 countries. 39 are recruiting or about to start. 105 of them are mainly about Breast Cancer Lymphedema (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Breast Cancer Lymphedema studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
57
Recruiting
24
Not yet recruiting
15
Status unknown
13
Active, not recruiting
10
Withdrawn
2

Phase

Phase 2
4
Phase 3
2
Phase 1
2
Phase 4
1

Where

Turkey
34
United States
15
China
12
Egypt
9
Spain
7
Belgium
6

Who runs them

Marmara University (6) · Cairo University (4) · Massachusetts General Hospital (4) · Violeta Pajero Otero (3) · Samsung Medical Center (3) · Ege University (3) · Assiut University (3) · Dokuz Eylul University (3)

What is being tested here

Drugs under test in Breast Cancer Lymphedema studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Indocyanine Green102
Tacrolimus001
Bupivacaine001
Triamcinolone001

Coming up

1phase 3 study under way
15studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 24 Breast Cancer Lymphedema studies recruiting now, 8 (33%) set no upper age limit and 9 (38%) stop at 75 or younger. 0 (0%) take children under 18. 20 (83%) are for women only and 0 (0%) for men only; 2 (8%) take healthy volunteers.

Recruiting studies that take each age, of 24
AgeWomenMen
100 (0%)0 (0%)
1819 (79%)3 (13%)
3023 (96%)4 (17%)
4023 (96%)4 (17%)
5024 (100%)4 (17%)
6523 (96%)4 (17%)
7518 (75%)3 (13%)
8511 (46%)3 (13%)

Across all 124 studies, recruiting or not: 48% stop at 75 or younger and 26% at 65; 4% take children; 84% are for women only and 0% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Breast Cancer Lymphedema studies take

Of 69 interventional studies with no phase under Breast Cancer Lymphedema, half reached primary completion within 18 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase18 mo10–34 · 69 studies—18 mo10–34 · 66 studies
Observational12 mo6–27 · 12 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 124. Browse all 124 → or search them.